Movers and Shakers

This week brought about as good a reaction to last week’s sharp selloff as you could have asked for. The major indexes generally held their 50-day lines and bounced nicely, and the same goes for all of the liquid leading stocks. Thus, by our measures, the market’s trends remain up and the odds favor higher prices going forward.

That said, the broad market remains extremely split and volatile. Even during the rally this week, there have been dozens of stocks hitting new lows on the NYSE every day. Plus, leadership ranks remain thin, and even among stocks that are acting well, many are running into selling pressure as soon as they punch out to new highs.

This so-so action among individual stocks keeps us relatively neutral. We’re all for holding your top performers (though booking some partial profits on the way up is prudent) and looking to buy the best stocks at attractive entry points, focusing on the best stories and set-ups—but it’s also smart to hold some cash.

The good news is that the action of the past two weeks may have put the finishing touches on some basing patterns among potential leaders. If we see some of these stocks emerge to new highs (or off support), it would give the market more leadership and provide us with more stocks to really sink our teeth into. That’s what we’ll be watching for during the next week or two.

This is an excerpt from Cabot Top Ten Trader, which features the best trades to make every week.  Designed for experienced investors who want even more great growth stock ideas, this advisory recommends the best 10 stocks each month for short-term investment by aggressive growth investors.

Michael Cintolo is Cabot's Vice President of Investments and Chief Analyst of Cabot Growth Investor and Cabot Top Ten Trader. To read customer reviews of Cabot Top Ten Trader, click here. To read reviews of Cabot Growth Investor, click here.

Michael Cintolo can be found on Google Plus.

Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.


Biogen is the market-share leader in treating multiple sclerosis.


One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >

AMZN Stock vs. FB Stock: Which Is the Better Value Buy?

By J. Royden Ward on September 20, 2016

For the past five years, AMZN stock and FB stock have been two of the market's great growth stories. But could you make the case that either stock is still undervalued? Let’s break it down.Read More >